Diagnostics & Research
The Diagnostics & Research industry has a total of 48 stocks, with a combined market cap of $673.87 billion, total revenue of $169.45 billion and a weighted average PE ratio of 38.66.
Market Cap
673.87B
Revenue
169.45B
Profits
17.43B
PE Ratio
38.66
Profit Margin
10.29%
Dividend Yield
0.25%
48 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 177.71B | 4.82% | 1,022,572 | 45.20B |
| 2 | DHR | Danaher Corporation | 126.54B | 3.26% | 1,351,021 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.45B | 2.26% | 147,810 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 37.99B | 16.20% | 2,211,487 | 7.23B |
| 5 | WAT | Waters Corporation | 35.52B | 5.72% | 264,248 | 3.77B |
| 6 | NTRA | Natera, Inc. | 29.37B | 0.96% | 614,095 | 2.50B |
| 7 | IQV | IQVIA Holdings Inc. | 29.31B | 6.04% | 357,858 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 23.72B | 4.40% | 421,838 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 23.14B | 4.68% | 44,124 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.65B | 0.83% | 84,482 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 21.49B | 1.48% | 97,630 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 17.16B | 1.51% | 603,947 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 12.61B | 3.15% | 65,052 | 2.68B |
| 14 | RVTY | Revvity, Inc. | 11.19B | 3.65% | 1,546,639 | 2.90B |
| 15 | ICLR | ICON Public Limited Company | 10.23B | 13.05% | 1,213,330 | 8.25B |
| 16 | CRL | Charles River Laboratories International, Inc. | 8.45B | 6.62% | 128,159 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 7.63B | 2.10% | 371,139 | 2.10B |
| 18 | SHC | Sotera Health Company | 4.49B | 1.22% | 426,277 | 1.19B |
| 19 | BLLN | BillionToOne, Inc. | 4.36B | 4.03% | 129,679 | 354.54M |
| 20 | RDNT | RadNet, Inc. | 4.26B | 0.69% | 62,912 | 2.14B |
| 21 | TWST | Twist Bioscience Corporation | 4.25B | 6.28% | 435,939 | 409.48M |
| 22 | VCYT | Veracyte, Inc. | 3.75B | 5.61% | 189,876 | 541.74M |
| 23 | GRAL | GRAIL, Inc. | 3.35B | 9.21% | 285,864 | 156.12M |
| 24 | ADPT | Adaptive Biotechnologies Corporation | 2.38B | 7.30% | 302,924 | 295.41M |
| 25 | WGS | GeneDx Holdings Corp. | 1.51B | 5.68% | 373,316 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.29B | 3.71% | 206,457 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.16B | 1.17% | 137,494 | 412.82M |
| 28 | PSNL | Personalis, Inc. | 1.08B | 8.96% | 1,437,385 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 1.06B | 7.69% | 1,672,965 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 668.93M | 3.74% | 56,739 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 525.84M | 3.44% | 83,979 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 394.79M | 6.36% | 414,198 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 308.30M | 6.14% | 75,551 | 92.39M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 208.59M | 0.78% | 10,179 | 1.95M |
| 35 | BDSX | Biodesix, Inc. | 157.59M | 5.27% | 29,459 | 96.10M |
| 36 | FONR | FONAR Corporation | 124.98M | 0.29% | 225,630 | 105.34M |
| 37 | XGN | Exagen Inc. | 122.97M | 1.60% | 188,202 | 68.38M |
| 38 | BNR | Burning Rock Biotech Limited | 111.90M | -12.82% | 17,821 | 77.14M |
| 39 | PRPO | Precipio, Inc. | 43.10M | 2.55% | 13,164 | 25.83M |
| 40 | QUCY | Quantum Cyber N.V. | 38.42M | 4.78% | 2,175,780 | 537.08K |
| 41 | MDXH | MDxHealth SA | 37.80M | -1.87% | 212,275 | 110.97M |
| 42 | MBAI | Check-Cap Ltd. | 12.65M | 2.06% | 22,116 | - |
| 43 | XWEL | XWELL, Inc. | 11.48M | -1.45% | 39,607 | 28.83M |
| 44 | NOTV | Inotiv, Inc. | 9.84M | 5.62% | 783,568 | 507.36M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 7.24M | -2.42% | 64,211 | 5.66M |
| 46 | NDRA | ENDRA Life Sciences Inc. | 6.95M | 4.48% | 16,737 | - |
| 47 | ADVB | Advanced Biomed Inc. | 6.38M | -0.52% | 8,116 | - |
| 48 | ISPC | iSpecimen Inc. | 4.69M | -2.69% | 111,339 | 1.03M |